key: cord-0850440-wmcj4b0f authors: Escandón, Kevin; Ulrich, Angela K; Chou, Roger title: Concerns with and recommendations for COVID-19 research related to asymptomatic infection and mask wearing date: 2021-03-23 journal: Clin Infect Dis DOI: 10.1093/cid/ciab257 sha: e16ec6b004e09f0671b5cac6724151432b395fcf doc_id: 850440 cord_uid: wmcj4b0f nan M a n u s c r i p t 2 TO THE EDITOR-We read with interest the recent study by Sims et al. [1] . The authors of this serological study of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among 20,614 healthcare workers (HCWs) in Michigan, US concluded that employees wearing an N95 filtering facepiece respirator (FFR) or a powered air-purifying respirator (PAPR) had a significantly higher asymptomatic SARS-CoV-2 infection (ASI) proportion relative to those wearing a surgical mask or -other mask‖. Herein we highlight some pressing concerns with this manuscript. First, the methods used likely resulted in misclassification of ASI status. Symptom status was based on self-report within a 30-day window prior to blood collection between April 13 and May 28, 2020. Since seropositivity reflects cumulative exposure, persons who were infected more than 30 days prior would have been classified as ASI, regardless of whether they had symptoms at the time of infection. In addition, reliance on serology excluded employees with recent infection who had not yet seroconverted; the time to seroconversion and antibody kinetics may vary with symptom status [2, 3] . For a more accurate assessment of ASI status, we suggest a sensitivity analysis that excludes all participants who reported a COVID-19 diagnosis 30 days or more before the study-associated blood draw and SARS-CoV-2-positive participants with symptoms within 2 weeks of the blood draw. In assessing ASI, future studies should provide comprehensive case definitions, granular symptom assessment via standardized questionnaires, follow-up of symptom status, and polymerase chain reaction testing results if available [4, 5] , to avoid much of the potential misclassification of presymptomatic, paucisymptomatic, and postsymptomatic individuals as asymptomatic. interactions not only related to patient care but also between HCWs not wearing personal protective equipment can lead to transmission [6] [7] [8] . Additional potential confounders include SARS-CoV-2 testing, interventions other than mask wearing, consistency and appropriateness of mask wearing, host risk factors for COVID-19 severity, and pre-existing immunity [9, 10] . Furthermore, in a community with widespread transmission, it is difficult to link an infection to occupational exposure. All these limitations make it inherently challenging to conclude whether exposure was occupational and to determine the type of mask (if any) was used during the relevant exposure. The conclusions related to ASI and mask wearing should therefore be cautiously interpreted. All authors declare no conflicts of interest and have submitted the ICMJE Form for A c c e p t e d M a n u s c r i p t COVID-19 seropositivity and asymptomatic rates in healthcare workers are associated with job function and masking Viral and Antibody Kinetics of COVID-19 Patients with Different Disease Severities in Acute and Convalescent Phases: A 6-Month Follow-Up Study Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) COVID-19 and false dichotomies: time to change the black-or-white messaging about health, economy, SARS-CoV-2 transmission, and masks Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2 What are the sources of exposure in healthcare personnel with coronavirus disease 2019 infection? Specific risk factors for SARS-CoV-2 transmission among health care workers in a university hospital Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers Facial Masking for Covid-19 Appropriate usage of face masks to prevent SARS-CoV-2: sharpening the messaging amid the COVID-19 pandemic